These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11932299)

  • 21. Genetic determinants of insulin action in polycystic ovary syndrome.
    Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GALNT2 Gene Variant rs4846914 Is Associated with Insulin and Insulin Resistance Depending on BMI in PCOS Patients: a Case-Control Study.
    Chen J; Guan L; Liu H; Liu Q; Fan P; Bai H
    Reprod Sci; 2021 Apr; 28(4):1122-1132. PubMed ID: 33171515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians.
    Vollmert C; Hahn S; Lamina C; Huth C; Kolz M; Schöpfer-Wendels A; Mann K; Bongardt F; Mueller JC; Kronenberg F; Wichmann HE; Herder C; Holle R; Löwel H; Illig T; Janssen OE;
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E836-44. PubMed ID: 17106059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
    Jones MR; Mathur R; Cui J; Guo X; Azziz R; Goodarzi MO
    J Clin Endocrinol Metab; 2009 Dec; 94(12):5034-8. PubMed ID: 19837928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Defining constant versus variable phenotypic features of women with polycystic ovary syndrome using different ethnic groups and populations.
    Welt CK; Arason G; Gudmundsson JA; Adams J; Palsdóttir H; Gudlaugsdóttir G; Ingadóttir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4361-8. PubMed ID: 16940441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
    Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
    J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor (VEGFA) gene variation in polycystic ovary syndrome in a Tunisian women population.
    Ben Salem A; Megdich F; Kacem O; Souayeh M; Hachani Ben Ali F; Hizem S; Janhai F; Ajina M; Abu-Elmagd M; Assidi M; Al Qahtani MH; Mahjoub T
    BMC Genomics; 2016 Oct; 17(Suppl 9):748. PubMed ID: 27766947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calpain-10 genetic polymorphisms and polycystic ovary syndrome risk: a meta-analysis and meta-regression.
    Shen W; Li T; Hu Y; Liu H; Song M
    Gene; 2013 Dec; 531(2):426-34. PubMed ID: 23994294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.
    Biyasheva A; Legro RS; Dunaif A; Urbanek M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2617-25. PubMed ID: 19351735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.
    Palmer ND; Goodarzi MO; Langefeld CD; Ziegler J; Norris JM; Haffner SM; Bryer-Ash M; Bergman RN; Wagenknecht LE; Taylor KD; Rotter JI; Bowden DW
    Diabetes; 2008 Apr; 57(4):1093-100. PubMed ID: 18252897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-nucleotide polymorphism of INS, INSR, IRS1, IRS2, PPAR-G and CAPN10 genes in the pathogenesis of polycystic ovary syndrome.
    Thangavelu M; Godla UR; Paul Solomon FD; Maddaly R
    J Genet; 2017 Mar; 96(1):87-96. PubMed ID: 28360393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome.
    Wickham EP; Ewens KG; Legro RS; Dunaif A; Nestler JE; Strauss JF
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E719-27. PubMed ID: 21252242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population.
    Malecki MT; Moczulski DK; Klupa T; Wanic K; Cyganek K; Frey J; Sieradzki J
    Eur J Endocrinol; 2002 May; 146(5):695-9. PubMed ID: 11980626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism of glycogen synthetase gene in polycystic ovary syndrome.
    Rajkhowa M; Talbot JA; Jones PW; Clayton RN
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):85-90. PubMed ID: 8706299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.
    Rasmussen SK; Urhammer SA; Berglund L; Jensen JN; Hansen L; Echwald SM; Borch-Johnsen K; Horikawa Y; Mashima H; Lithell H; Cox NJ; Hansen T; Bell GI; Pedersen O
    Diabetes; 2002 Dec; 51(12):3561-7. PubMed ID: 12453914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women.
    Zhang N; Shi YH; Hao CF; Gu HF; Li Y; Zhao YR; Wang LC; Chen ZJ
    Eur J Endocrinol; 2008 Feb; 158(2):255-60. PubMed ID: 18230834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
    Sáez ME; Martínez-Larrad MT; Ramírez-Lorca R; González-Sánchez JL; Zabena C; Martinez-Calatrava MJ; González A; Morón FJ; Ruiz A; Serrano-Ríos M
    BMC Med Genet; 2007 Jan; 8():1. PubMed ID: 17227582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
    Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
    Horm Metab Res; 2011 Jun; 43(6):427-32. PubMed ID: 21448847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.